p.K150N | TCGA-D3-A1Q3 | SKCM | TCGA | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation substituting flanking lysine | 0.25 |
p.K150N | DO47509 | SKCM | ICGC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation substituting flanking lysine | 0.25 |
p.G164E | TCGA-DA-A3F8 | SKCM | TCGA | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation rewiring degron network | 0.3056 |
p.S153L | TCGA-EA-A410 | CESC | TCGA | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation blocking phosphorylation signal | 0.6667 |
p.S153L | DO49929 | CESC | ICGC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation blocking phosphorylation signal | 0.6667 |
p.E169K | TCGA-EE-A181 | SKCM | TCGA | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation rewiring degron network | 0.1667 |
p.E169K | DO37444 | SKCM | ICGC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation rewiring degron network | 0.1667 |
p.R149H | DO227988 | COCA | ICGC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation rewiring degron network | 0.1111 |
p.P160S | DO234420 | ESAD | ICGC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.6752 |
p.T159M | DO233888 | GACA | ICGC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7423 |
p.R149C | DO51039 | LAML | ICGC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation rewiring degron network | 0.1111 |
p.E155K | DO218861 | SKCA | ICGC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation rewiring degron network | 0.2778 |
p.T163A | SIDM00557 | Neuroblastoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00390 | T-Cell Non-Hodgkin's Lymphoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00584 | Osteosarcoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00602 | Gastric Carcinoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00551 | Esophageal Squamous Cell Carcinoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00193 | Colorectal Carcinoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00264 | Ewing's Sarcoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00457 | Plasma Cell Myeloma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM01148 | Plasma Cell Myeloma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00235 | Kidney Carcinoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00587 | Biliary Tract Carcinoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00549 | B-Lymphoblastic Leukemia | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00986 | Head and Neck Carcinoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00996 | Thyroid Gland Carcinoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM00381 | Cervical Carcinoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM01526 | Mesothelioma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM01749 | Osteosarcoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM01435 | Hepatocellular Carcinoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |
p.T163A | SIDM01763 | Rhabdomyosarcoma | GDSC | IFTPLQT | DEG_SCF_FBW7_1 | 157:163 | Mutation altering degron motif | 0.7139 |